Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFECT OF NUV001 SUPPLEMENTATION FOR 120 DAYS IN PATIENTS SUFFERING FROM SICKLE CELL DISEASE (SCD) SS GENOTYPE: A PILOT STUDY

NCT05789355 is registered in ClinicalTrials.gov with LGD as lead sponsor.

NCT NCT05789355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05789355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFECT OF NUV001 SUPPLEMENTATION FOR 120 DAYS IN PATIENTS SUFFERING FROM SICKLE CELL DISEASE (SCD) SS GENOTYPE: A PILOT STUDY
Lead sponsor
LGD
Phase
Not applicable
Overall status
Completed
Start date
March 30, 2023
Completion date
May 6, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease